Recombinant SLC1A5 (Idactamab Biosimilar) antibody
Quick Overview for Recombinant SLC1A5 (Idactamab Biosimilar) antibody (ABIN7675832)
Target
Antibody Type
Reactivity
Host
Clonality
Application
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-SLC1A5 / ASCT2 Reference Antibody (idactamab)
-
Characteristics
- Anti-SLC1A5 / ASCT2 Reference Antibody (idactamab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG1
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
Therapeutic Agents by Target and Mechanism: ASCT2 inhibitors
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- SLC1A5 (Idactamab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- Q15758
Target
-